Emerging agents that target signaling pathways in cancer stem cells.

Citation metadata

Date: May 26, 2020
From: Journal of Hematology & Oncology(Vol. 13, Issue 1)
Publisher: BioMed Central Ltd.
Document Type: Article
Length: 9,575 words
Lexile Measure: 1480L

Document controls

Main content

Abstract :

Cancer stem cells (CSCs) contribute to the initiation, recurrence, and metastasis of cancer; however, there are still no drugs targeting CSCs in clinical application. There are several signaling pathways playing critical roles in CSC progression, such as the Wnt, Hedgehog, Notch, Hippo, and autophagy signaling pathways. Additionally, targeting the ferroptosis signaling pathway was recently shown to specifically kill CSCs. Therefore, targeting these pathways may suppress CSC progression. The structure of small-molecule drugs shows a good spatial dispersion, and its chemical properties determine its good druggability and pharmacokinetic properties. These characteristics make small-molecule drugs show a great advantage in drug development, which is increasingly popular in the market. Thus, in this review, we will summarize the current researches on the small-molecule compounds suppressing CSC progression, including inhibitors of Wnt, Notch, Hedgehog, and autophagy pathways, and activators of Hippo and ferroptosis pathways. These small-molecule compounds emphasize CSC importance in tumor progression and propose a new strategy to treat cancer in clinic via targeting CSCs. Keywords: Cancer stem cells, Small-molecule compounds, Wnt, Hedgehog, Notch, Hippo, Autophagy, Ferroptosis

Source Citation

Source Citation   

Gale Document Number: GALE|A627357013